Ophthalmology Summit 2019
Ophthalmology Case Reports | Volume 3
Note:
OF EXCELLENCE
IN INTERNATIONAL
MEETINGS
alliedacademies.comYEARS
March 27-28, 2019 | Amsterdam, Netherlands
2
nd
GLOBAL
OPHTHALMOLOGY SUMMIT 2019
Page48
MACULAR THICKNESS AND ITS RELATION WITH AGE AND GENDER IN
HEALTHY EYES IN A SAMPLE OF IRAQI POPULATION USING CIRRUS-HD
OPTICAL COHERENCE TOMOGRAPHY
Qasim Farhood
College of Medicine Babylon, Iraq
O
ptical coherence tomography (OCT) has been introduced as a useful imaging method by providing
high-resolution and cross sectional information about various pathological conditions of macula and has
gained increased importance in the diagnosis, management and monitoring of patients with various retinal
disorders.
Purpose of the study:
To provide a normative data for macular thickness in healthy Iraqi eyes using Zeiss
cirrus HD-OCT and to determine the effects of age and gender on their measurements.
Materials and methods:
Two hundred healthy adult volunteers (≥20 years) underwent macular cube scan-
ning using Zeiss cirrus-HD OCT. Macular thickness from all 9 regions of the early treatment Diabetic Retinop-
athy Study map was documented for each subject. Variations in macular thickness by age and gender were
determined.
Results:
The mean age of volunteers was 37±10.4 (range 21-67)years. The mean of central foveal thickness
was 254.6±17.3Mm, the mean macular thickness was 279.0 ± 10.7 Mm and the macular volume was 10.0 ± 0.4
mm3.Females were found to have a significantly thinner macula (P< 0.001) than males in all 9 ETDRS regions
except outer inferior quadrant. Central foveal thickness was found to have very weak correlation with age
which was not statistically significant. All other macular regions, mean macular thickness and volume showed
statistically significant nonlinear reduction with age(p value<0.001).
Conclusion:
This is a normative data for macular thickness in healthy Iraqi eyes using Zeiss cirrus HD-OCT. This
will serve as a baseline for diagnosing and treating macular pathologies in Iraqi eyes.
Ophthalmol Case Rep 2019, Volume 3